When CBD treatment effects were tested in dyadic social interactions with an unrestrained stranger mouse in an MK-801 model of schizophrenia, they found the 5-HT1A antagonist WAY100635, but not CB1 antagonist AM251 or CB2 receptor antagonist AM630 blocked the ability of CBD to enhance social interactions (40). Here, OPN1MW is linked to schizophrenia.